Anúncio
Anúncio
NAGE
Niagen Bioscience, Inc. Common Stock
6.52
USDPatrocinado
-0.03
-0.53%
09 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
6.56
+0.04
+0.61%
Relatórios de Lucros NAGE
Rácio de surpresa positiva
NAGE separação 20 de 36 últimas estimativas.
56%
Próximo Relatório
Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$32.34M
/$0.02
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-4.85%
/-60.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+11.04%
/-77.78%
Niagen Bioscience, Inc. Common Stock earnings per share and revenue
On 04 de nov. de 2025, NAGE reported earnings of 0.05 USD per share (EPS) for Q3 25, beating the estimate of 0.01 USD, resulting in a 206.75% surprise. Revenue reached 33.99 milhão, compared to an expected 31.72 milhão, with a 7.13% difference. The market reacted with a -1.01% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analistas forecast an EPS of 0.02 USD, with revenue projected to reach 32.34 milhão USD, implying an diminuir of -60.00% EPS, and diminuir of -4.85% in Revenue from the last quarter.
FAQ
What were Niagen Bioscience, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Niagen Bioscience, Inc. Common Stock reported EPS of $0.05, beating estimates by 206.75%, and revenue of $33.99M, 7.13% above expectations.
How did the market react to Niagen Bioscience, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -1.01%, changed from $6.95 before the earnings release to $6.88 the day after.
When is Niagen Bioscience, Inc. Common Stock expected to report next?
The next earning report is scheduled for 02 de mar. de 2026.
What are the forecasts for Niagen Bioscience, Inc. Common Stock's next earnings report?
Based on 7
analistas, Niagen Bioscience, Inc. Common Stock is expected to report EPS of $0.02 and revenue of $32.34M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio